Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (21)

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  2. Optimization of the molecular diagnosis of the acute hepatitis E virus infection

    Microbial Biotechnology, Vol. 16, Núm. 6, pp. 1325-1332

2022

  1. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2021

  1. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  2. Prevalence of Colorectal Neoplasms Among Patients With Enterococcus faecalis Endocarditis in the GAMES Cohort (2008–2017)

    Mayo Clinic Proceedings, Vol. 96, Núm. 1, pp. 132-146

2020

  1. GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000–2016)

    Journal of Infection, Vol. 81, Núm. 4, pp. 600-606

2019

  1. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2018

  1. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

    Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562

2017

  1. Infective endocarditis in patients with cancer: A consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohort

    Medicine (United States), Vol. 96, Núm. 38

  2. Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study)

    Journal of Viral Hepatitis, Vol. 24, Núm. 9, pp. 725-732

2015

  1. Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study

    Medicine (United States), Vol. 94, Núm. 43

  2. Left-sided infective endocarditis in patients with liver cirrhosis

    Journal of Infection, Vol. 71, Núm. 6, pp. 627-641

2014

  1. Molecular epidemiology and virulence of Escherichia coli O16: H5-ST131: Comparison with H30 and H30-Rx subclones of O25b: H4-ST131

    International Journal of Medical Microbiology, Vol. 304, Núm. 8, pp. 1247-1257

2013

  1. Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: Bacterial, epidemiological, and clinical characteristics

    Journal of Clinical Microbiology, Vol. 51, Núm. 10, pp. 3358-3367

  2. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2011

  1. Characterisation of clinical and food animal Escherichia coli isolates producing CTX-M-15 extended-spectrum β-lactamase belonging to ST410 phylogroup A

    International Journal of Antimicrobial Agents, Vol. 37, Núm. 4, pp. 365-367

  2. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 9, pp. 2011-2021

2010

  1. Diversity of Escherichia coli strains producing extended-spectrum β-lactamases in Spain: Second nationwide study

    Journal of Clinical Microbiology, Vol. 48, Núm. 8, pp. 2840-2845

2008

  1. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229